PET-CT Doses
Veterans Affairs · 255-NETWORK CONTRACT OFFICE 15 (36C255)
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 36C25526Q0035 in this department, oldest first.
- Oct 29, 2025 · this noticeCombined Synopsis/Solicitation
- Jan 12, 2026Award NoticeSOFIE Co. DULLES 20166 · $1.4MOpen
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Decide bid or no bid before the response deadline.
- Look at the past winners for likely competitors and teaming partners.
- Follow the opportunity to hear about amendments and the award.
What the notice says
Contractor agrees to provide all needed radiopharmaceuticals as identified in the Schedule of Supplies and Prices to Kansas City VA Medical Center, Kansas City, MO, located at 4801 E. Linwood Blvd, Kansas City, MO 64128 on a daily and/or as needed basis per this Statement of Work.
Who won similar work
3 award notices on SAM.gov in the last 24 months. Matched by: Same office (255-NETWORK CONTRACT OFFICE 15 (36C255)), same NAICS 325412.
Single-winner award sizes (3): middle half $547K to $814K, median $737K; range $358K to $892K.
| Winner | Awards | Value | Last |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 2 | $1.6M | Aug 21, 2026 |
| OPTUM INFUSION SERVICES 308, LLC | 1 | $358K | Aug 31, 2026 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.
- Aug 31, 2026OPTUM INFUSION SERVICES 308, LLC$358KQ517--36C25526D0052 | Pharmacy Compounded Sterile Preparation (CSP) Contingency | Optum Infusion Services 308, LLC | VISN 15 | 09/01/2026 - 08/31/2031 |No listed company matched (Materiality N/A)
- Aug 21, 2026Novartis Pharmaceuticals Corporation$892K6505--ME/ New Pluvicto Theronastic Therapy Radiopharmaceuticals/STL(VA-26-00053903) 657-26-4-1642-0063No listed company matched (Materiality N/A)
- Aug 11, 2025Novartis Pharmaceuticals Corporation$737K6505--Pluvicto, STL 36C255-25-AP-0008No listed company matched (Materiality N/A)
Competitive landscape
For the 2 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 0 of these past winners lobbied Veterans Affairs, Dept of (VA) since 2024 (0 filings)
- 0 of their lobbyists list a past Veterans Affairs, Dept of (VA) job
- No corporate PAC money from them to the overseeing committees since 2024
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 25 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 0 of the past winners are listed companies
- 0 insider buys and 0 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.